The global pharmaceutical unit dose packaging market is on a remarkable growth trajectory, with a forecasted valuation of US$ 34.2 billion in 2023 and a projected surge to US$ 136 billion by 2033, reflecting an impressive compound annual growth rate (CAGR) of 14.8%. This surge is largely attributed to the thriving pharmaceutical sector, which continues to expand rapidly due to significant technological and scientific advancements.
The pharmaceutical industry’s dynamic growth is a key driver behind the increasing demand for pharmaceutical unit dose packaging solutions. As pharmaceutical companies seek to optimize their operations and meet the growing global healthcare needs, efficient and precise unit dose packaging becomes essential.
Another significant factor fueling the market’s growth is the mounting concern about drug wastage. Medication wastage not only has a substantial financial impact on the healthcare system but also contributes to adverse environmental consequences. Consequently, the adoption of unit dose packaging is gaining prominence as a sustainable solution, further propelling the market’s upward trajectory. As the pharmaceutical industry evolves and emphasizes efficiency and sustainability, unit dose packaging is poised to play a pivotal role in its continued success.
Read a Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-5236
An increase in the supply of active pharmaceutical ingredients (APIs) is further fuelling the demand for blister-based unit dose packaging. The new developments in API manufacturing and development facilities are helping the market to grow.
A surge in demand for child-resistant and senior-friendly packaging is further boosting product demand. Unit dose packaging options are designed to avoid accidental ingestion of drugs by children and older adults. This help in improving patient safety and minimizing the risk of medication errors. Furthermore, the increasing number of prescription drugs is increasing revenue growth.
A rise in global spending on medicine is positively impacting the blister unit dose pharmaceutical packaging. Various developed countries are witnessing a better adoption rate for improved healthcare diagnostics and overall standards, including medicine. This is anticipated to augment growth in the market.
An increase in drug consumption rate is further driving product demand. On the other hand, the evolution of e-commerce platforms is contributing to simplifying drug access and also complying with the strict regulations for safe logistics.
Key Takeaways
- North America is expected to dominate the industry by accumulating over 38.6 % revenue share by end of the forecast period.
- The market in India is projected to witness the fastest CAGR of 7.90% during the forecast period.
- China is projected to exhibit a 6.90 % of CAGR in Pharmaceutical Unit Dose Packaging market.
- By packaging type, vials are projected to account for 35% market share by end of the forecast period.
- By material type, Plastic is expected to lead the market by withholding 47.9 % of revenue share in 2023.
“A surge in demand for over-the-counter drugs will especially create a favorable ground for pharmaceutical packaging materials. In addition, increasing preference for single-dose packaging formats, and rapid expansion of e-Pharmacy will further propel growth in the market”- comments an FMI Analyst
Competitive Landscape
The Pharmaceutical Unit Dose Packaging market is extremely competitive and consists of numerous key industry players. These players are innovating new products in the respiratory devices domain. This is expected to propel the pharmaceutical unit dose packaging market. The key industry players are:
Gerresheimer AG, West Pharmaceuticals Services, Inc, Schott AG, SGD SA, Stevanato Group S.p.a., Klockner Pentaplast Group, UDG Healthcare plc., Nipro Corporation, Amcor plc., Adelphi Healthcare Packaging, Winpak Ltd., Berry Global, Inc., Comar LLC, Constantia Flexibles Group GmbH, Catalent Inc., Becton, Dickinson and Company, Pacific Vial Manufacturing Inc., Sonoco Products Company, WestRock Company, AptarGroup, Inc.
Key market players are leveraging on inorganic growth strategies like acquisition, mergers, partnerships, and collaboration in order to enhance their product portfolio. This is expected to fuel the global Pharmaceutical Unit Dose Packaging Market.
- In May 2021, ‘Gerresheimer’ showcased a new platform for on body infusion pump “SensAIR” that can deliver drugs of high viscosity. It is simple to use and helps in the self-determination of medication.
- In January 2022, ‘Berry Global Group’ and ‘Raw Elements USA’ collaborated to introduce a sugarcane-based sustainable tube. The tubes are manufactured from waste sugarcane, which is converted into high-density polyethylene and low-density polyethylene to make a material with the same chemical composition as polyethylene obtained from fossil fuels.
- In June 2021, Amcor PLC introduced the ‘ACT2100’ heat seal coating for use with medical-grade DuPont Tyvek2 and paper packaging. This innovative coating process enhances the performance characteristics of medical applications.
More Valuable Insights Available
Future Market Insights offers an unbiased analysis of the global pharmaceutical unit dose packaging market, providing historical data for 2018 to 2022 and forecast statistics from 2023 to 2033.
To understand opportunities in the pharmaceutical unit dose packaging market, the market is segmented on the basis of product, material, end-use, and regions.
Request Report Methodology: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-5236
Key Segments:
By Product:
- Blisters
- Ampoules
- Vials
- Prefilled Syringes & Cartridges
By Material:
- Plastic
-
- Polyethylene
- Polypropylene
- Polyvinyl Chloride
- Polyethylene Terephthalate
- Aluminium
- Glass
- Paper & Paperboard
By End Use:
- Ophthalmic
- Injectable
- Biologics
- Wound Care
- Respiratory Therapy
- Orals
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
